JERMAINE NNAETO: Open Payments
NPI 1962264812 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $452 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $87 |
| Teva Pharmaceuticals USA, Inc. | 1 | $61 |
| Supernus Pharmaceuticals, Inc. | 3 | $43 |
| Dexcom, Inc. | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| Alkermes, Inc. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: VRAYLAR, AUSTEDO XR, Qelbree, Dexcom G6 Transmitter, COBENFY, Auvelity, ARISTADA, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
